Journal of Cellular & Molecular Anesthesia

Cooper C, Javaid MK, Arden N. Epidemiology of osteoarthritis. Atlas of osteoarthritis: Springer; 2014. p. 21-36.

Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis. 2016;2:16072.

Aigner T, Rose J, Martin J, Buckwalter J. Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Research. 2004;7(2):134-45.

Brooks PM. Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Current opinion in rheumatology. 2002;14(5):573-7.

Malfait A-M, Schnitzer TJ. Towards a mechanism-based approach to pain management in osteoarthritis. Nat Rev Rheumatol. 2013;9(11):654-64.

Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best practice & research Clinical rheumatology. 2006;20(1):3-25.

Lotz MK. New developments in osteoarthritis: posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options. Arthritis research & therapy. 2010;12(3):211.

Yusuf E, Nelissen R, Ioan-Facsinay A, et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Annals of the rheumatic diseases. 2009.

Buckwalter JA, Mankin HJ, Grodzinsky AJ. Articular cartilage and osteoarthritis. Instructional Course Lectures-American Academy of Orthopaedic Surgeons. 2005;54:465.

Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Therapeutic Advances in Musculoskeletal Disease. 2013;5(2):77-94.

Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249-57.

Houard X, Goldring MB, Berenbaum F. Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Current rheumatology reports. 2013;15(11):375.

Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nature Reviews Rheumatology. 2010;6(11):625-35.

Gardner GC. Inflammatory arthritis in the era of the biologics. Clinical and Applied Immunology Reviews. 2005;5(1):19-44.

Huang K, Wu L. Aggrecanase and aggrecan degradation in osteoarthritis: a review. Journal of International Medical Research. 2008;36(6):1149-60.

Roughley P. The structure and function of cartilage proteoglycans. Eur Cell Mater. 2006;12(9).

Gemmell HA, Jacobson BH, Hayes BM. Effect of a topical herbal cream on osteoarthritis of the hand and knee: a pilot study. Journal of manipulative and physiological therapeutics. 2003;26(5):322.

Lai LH, Chan FLK. What is the optimal anti-inflammatory therapy for patients with osteoarthritis and increased cardiovascular risk? Nat Clin Pract Gastroenterol Hepatol. 2008;5(5):240-1.

Jozwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta poloniae pharmaceutica. 2014;71(1):11-23.

Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Journal of the American College of Cardiology. 2008;52(18):1502-17.

Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115(12):1634-42.

Friedewald VE, Bennett JS, Christo JP, et al. AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. The American journal of cardiology. 2010;106(6):873-84.

Ofman JJ, MacLean CH, Straus WL, et al. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. The Journal of rheumatology. 2002;29(4):804-12.

Ivers N, Dhalla IA, Allan GM. Opioids for osteoarthritis pain: benefits and risks. Canadian Family Physician. 2012;58(12):e708-e.

Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Archives of internal medicine. 2010;170(22):1968-76.

Ernst E, Resch K, Mills S, et al. Complementary medicine—a definition. Br J Gen Pract. 1995;45(398):506-.

Selfe TK, Taylor AG. Acupuncture and Osteoarthritis of the Knee: A Review of Randomized, Controlled Trials. Family & community health. 2008;31(3):247-54.

Iannitti T, Fistetto G, Esposito A, Rottigni V, Palmieri B. Pulsed electromagnetic field therapy for management of osteoarthritis-related pain, stiffness and physical function: clinical experience in the elderly. Clinical Interventions in Aging. 2013;8:1289-93.

Ernst E. Herbal medicine in the treatment of rheumatic diseases. Rheumatic diseases clinics of North America. 2011;37(1):95-102.

Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Alternative medicine review. 2009;14(2).

Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochemical pharmacology. 2008;75(4):787-809.

Mathy-Hartert M, Jacquemond-Collet I, Priem F, Sanchez C, Lambert C, Henrotin Y. Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res. 2009;58(12):899-908.

Csaki C, Mobasheri A, Shakibaei M. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther. 2009;11(6):R165.

Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. British journal of pharmacology. 2013;169(8):1672-92.

Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. The international journal of biochemistry & cell biology. 2009;41(1):40-59.

Henrotin Y, Clutterbuck AL, Allaway D, et al. Biological actions of curcumin on articular chondrocytes. Osteoarthritis and cartilage. 2010;18(2):141-9.

Yeh CC, Su YH, Lin YJ, et al. Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis. Drug Des Devel Ther. 2015;9:2285-300.

Buhrmann C, Mobasheri A, Matis U, Shakibaei M. Curcumin mediated suppression of nuclear factor-kappaB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther. 2010;12(4):R127.

Pinsornsak P, Niempoog S. The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J Med Assoc Thai. 2012;95 Suppl 1:S51-8.

Kuptniratsaikul V, Thanakhumtorn S, Chinswangwatanakul P, Wattanamongkonsil L, Thamlikitkul V. Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. J Altern Complement Med. 2009;15(8):891-7.

Nakagawa Y, Mukai S, Yamada S, et al. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study. J Orthop Sci. 2014;19(6):933-9.

Tjendraputra E, Tran VH, Liu-Brennan D, Roufogalis BD, Duke CC. Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorganic chemistry. 2001;29(3):156-63.

Verma SK, Singh M, Jain P, Bordia A. Protective effect of ginger, Zingiber officinale Rosc on experimental atherosclerosis in rabbits. Indian journal of experimental biology. 2004;42(7):736-8.

Pan MH, Hsieh MC, Kuo JM, et al. 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Molecular nutrition & food research. 2008;52(5):527-37.

Jung HW, Yoon CH, Park KM, Han HS, Park YK. Hexane fraction of Zingiberis Rhizoma Crudus extract inhibits the production of nitric oxide and proinflammatory cytokines in LPS-stimulated BV2 microglial cells via the NF-kappaB pathway. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2009;47(6):1190-7.

Lantz RC, Chen GJ, Sarihan M, Solyom AM, Jolad SD, Timmermann BN. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2007;14(2-3):123-8.

Drozdov VN, Kim VA, Tkachenko EV, Varvanina GG. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip. The Journal of Alternative and Complementary Medicine. 2012;18(6):583-8.

Haghighi A, Tavalaei N, Owlia MB. Effects of ginger on primary knee osteoarthritis. Indian Journal of Rheumatology. 2006;1(1):3-7.

Altman RD, Marcussen K. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis & Rheumatology. 2001;44(11):2531-8.

Bartels EM, Folmer VN, Bliddal H, et al. Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis and cartilage. 2015;23(1):13-21.

Huang TH-W, Tran VH, Duke RK, et al. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-κB activation. Journal of ethnopharmacology. 2006;104(1):149-55.

Gyurkovska V, Alipieva K, Maciuk A, et al. Anti-inflammatory activity of Devil’s claw in vitro systems and their active constituents. Food Chemistry. 2011;125(1):171-8.

Loew D, Möllerfeld J, Schrödter A, Puttkammer S, Kaszkin M. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clinical Pharmacology & Therapeutics. 2001;69(5):356-64.

McGregor G, Fiebich B, Wartenberg A, Brien S, Lewith G, Wegener T. Devil’s claw (Harpagophytum procumbens): an anti-inflammatory herb with therapeutic potential. Phytochemistry Reviews. 2005;4(1):47-53.

Ernst E. Complementary or alternative therapies for osteoarthritis. Nat Clin Pract Rheum. 2006;2(2):74-80.

Brien S, Lewith GT, McGregor G. Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety. Journal of alternative and complementary medicine (New York, NY). 2006;12(10):981-93.

Rein E, Kharazmi A, Winther K. A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis—a double-blind, placebo-controlled, randomised trial. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2004;11(5):383-91.

Willich S, Rossnagel K, Roll S, et al. Rose hip herbal remedy in patients with rheumatoid arthritis–a randomised controlled trial. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2010;17(2):87-93.

Jäger AK, Eldeen IM, van Staden J. COX‐1 and‐2 activity of rose hip. Phytotherapy Research. 2007;21(12):1251-2.

Daels‐Rakotoarison D, Gressier B, Trotin F, et al. Effects of Rosa canina fruit extract on neutrophil respiratory burst. Phytotherapy research. 2002;16(2):157-61.

Orhan DD, Hartevioğlu A, Küpeli E, Yesilada E. In vivo anti-inflammatory and antinociceptive activity of the crude extract and fractions from Rosa canina L. fruits. Journal of ethnopharmacology. 2007;112(2):394-400.

Schwager J, Richard N, Wolfram S. 145 Anti-inflammatory and chondro-protecitve effects of rose hip powder and its constituent galactolipids gopo. Osteoarthritis and cartilage. 2008;16:S76.

Marstrand C, Warholm L, Kharazmi A, Winther K. The anti-inflammatory capacity of Rose-hip is strongly dependent on the seeds-a comparison of animal and human studies. Osteoarthritis and cartilage. 2013;21:S216-S7.

Warholm O, Skaar S, Hedman E, Molmen HM, Eik L. The Effects of a Standardized Herbal Remedy Made from a Subtype of Rosa canina in Patients with Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Current therapeutic research, clinical and experimental. 2003;64(1):21-31.

Winther K, Apel K, Thamsborg G. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial. Scandinavian journal of rheumatology. 2005;34(4):302-8.

Petcharat A, Wongsuphasawat K. The efficacy of a standardized Rose-hip powder containing seeds and shells compared with glucosamine sulfate in patients with osteoarthritis of the knee-a blinded, parallel, randomized study. Osteoarthritis and cartilage. 2013;21:S216.

Peng CH, Su JD, Chyau CC, et al. Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects. Bioscience, biotechnology, and biochemistry. 2007;71(9):2223-32.

Moreno S, Scheyer T, Romano CS, Vojnov AA. Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free radical research. 2006;40(2):223-31.

Sahu A, Rawal N, Pangburn MK. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b. Biochemical pharmacology. 1999;57(12):1439-46.

Nogueira de Melo GA, Grespan R, Fonseca JP, et al. Rosmarinus officinalis L. essential oil inhibits in vivo and in vitro leukocyte migration. Journal of medicinal food. 2011;14(9):944-6.

Amaral GP, de Carvalho NR, Barcelos RP, et al. Protective action of ethanolic extract of Rosmarinus officinalis L. in gastric ulcer prevention induced by ethanol in rats. Food and Chemical Toxicology. 2013;55:48-55.

Lukaczer D, Darland G, Tripp M, et al. A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia. Phytotherapy research : PTR. 2005;19(10):864-9.

Choi JH, Choi JH, Kim DY, et al. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model. Osteoarthritis and cartilage. 2002;10(6):471-8.

Jung YB, Roh KJ, Jung JA, et al. Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: a double-blind placebo controlled study. Am J Chin Med. 2001;29(3-4):485-91.

Cameron M, Chrubasik S. Oral herbal therapies for treating osteoarthritis. The Cochrane database of systematic reviews. 2014;5:CD002947-CD.

Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology. 2001;40(7):779-93.

Rains C, Bryson HM. Topical Capsaicin. Drugs & Aging. 1995;7(4):317-28.

National Center for Biotechnology Information. PubChem Compound Database; CID=1548943 hpnnngcaO, 2017). capsaicin. pubmed. 2017.

Spiller F, Alves MK, Vieira SM, et al. Anti-inflammatory effects of red pepper (Capsicum baccatum) on carrageenan- and antigen-induced inflammation. The Journal of pharmacy and pharmacology. 2008;60(4):473-8.

Kim CS, Kawada T, Kim BS, et al. Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal. 2003;15(3):299-306.

Kosuwon W, Sirichatiwapee W, Wisanuyotin T, Jeeravipoolvarn P, Laupattarakasem W. Efficacy of symptomatic control of knee osteoarthritis with 0.0125% of capsaicin versus placebo. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2010;93(10):1188-95.

Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ : British Medical Journal. 2004;328(7446):991-.

Laslett LL, Jones G. Capsaicin for osteoarthritis pain. Progress in drug research Fortschritte der Arzneimittelforschung Progres des recherches pharmaceutiques. 2014;68:277-91.

Riehemann K, Behnke B, Schulze-Osthoff K. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF‐κB. FEBS letters. 1999;442(1):89-94.

Chrubasik S, Enderlein W, Bauer R, Grabner W. Evidence for antirheumatic effectiveness of Herba Urticae dioicae in acute arthritis: a pilot study. Phytomedicine : international journal of phytotherapy and phytopharmacology. 1997;4(2):105-8.

Randall C, Randall H, Dobbs F, Hutton C, Sanders H. Randomized controlled trial of nettle sting for treatment of base-of-thumb pain. Journal of the Royal Society of Medicine. 2000;93(6):305-9.

Jacquet A, Girodet PO, Pariente A, Forest K, Mallet L, Moore N. Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial. Arthritis Res Ther. 2009;11(6):R192.

Au RY, Al-Talib TK, Au AY, Phan PV, Frondoza CG. Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage. 2007;15(11):1249-55.

Ownby SL, Fortuno LV, Au AY, Grzanna MW, Rashmir-Raven AM, Frondoza CG. Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination. Journal of Inflammation. 2014;11(1):8.

Lippiello L, Nardo JV, Harlan R, Chiou T. Metabolic effects of avocado/soy unsaponifiables on articular chondrocytes. Evid Based Complement Alternat Med. 2008;5(2):191-7.

Altinel L, Saritas ZK, Kose KC, Pamuk K, Aksoy Y, Serteser M. Treatment with unsaponifiable extracts of avocado and soybean increases TGF-beta1 and TGF-beta2 levels in canine joint fluid. The Tohoku journal of experimental medicine. 2007;211(2):181-6.

Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Revue du rhumatisme (English ed). 1997;64(12):825-34.

Appelboom T, Schuermans J, Verbruggen G, Henrotin Y, Reginster JY. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study. Scandinavian journal of rheumatology. 2001;30(4):242-7.

Maheu E, Mazieres B, Valat JP, et al. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum. 1998;41(1):81-91.

Christensen R, Bartels EM, Astrup A, Bliddal H. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis and cartilage. 2008;16(4):399-408.

Ernst E. Avocado-soybean unsaponifiables (ASU) for osteoarthritis - a systematic review. Clin Rheumatol. 2003;22(4-5):285-8.

Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2012;380(9859):2197-223.

Hawker GA, Wright JG, Coyte PC, et al. Differences between men and women in the rate of use of hip and knee arthroplasty. New England Journal of Medicine. 2000;342(14):1016-22.

Ong CKS, Lirk P, Tan CH, Seymour RA. An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs. Clinical Medicine and Research. 2007;5(1):19-34.

Ejaz P, Bhojani K, Joshi VR. NSAIDs and kidney. The Journal of the Association of Physicians of India. 2004;52:632-40.

Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain physician. 2008;11(2 Suppl):S105-20.

Wood AM, Brock TM, Heil K, Holmes R, Weusten A. A review on the management of hip and knee osteoarthritis. International journal of chronic diseases. 2013;2013.

Wang X, Zhang A, Zhou X, et al. An integrated chinmedomics strategy for discovery of effective constituents from traditional herbal medicine. 2016;6:18997.

Farzaei MH, Khanavi M, Moghaddam G, et al. Standardization of Tragopogon graminifolius DC. extract based on phenolic compounds and antioxidant activity. Journal of Chemistry. 2014;2014.

Marchev AS, Dimitrova PA, Burns AJ, Kostov RV, Dinkova-Kostova AT, Georgiev MI. Oxidative stress and chronic inflammation in osteoarthritis: can NRF2 counteract these partners in crime? Annals of the New York Academy of Sciences. 2017;1401(1):114-35.

Bent S. Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation: Grand Rounds at University of California, San Francisco Medical Center. Journal of General Internal Medicine. 2008;23(6):854-9.

Mushtaq S, Choudhary R, Scanzello CR. Non-surgical treatment of osteoarthritis-related pain in the elderly. Current Reviews in Musculoskeletal Medicine. 2011;4(3):113-22.